[Etiology, prevention and therapy of hyaline membrane disease]. 1968

J Boon, and E Schretlen

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006819 Hyaline Membrane Disease A respiratory distress syndrome in newborn infants, usually premature infants with insufficient PULMONARY SURFACTANTS. The disease is characterized by the formation of a HYALINE-like membrane lining the terminal respiratory airspaces (PULMONARY ALVEOLI) and subsequent collapse of the lung (PULMONARY ATELECTASIS). Disease, Hyaline Membrane,Diseases, Hyaline Membrane,Hyaline Membrane Diseases
D000109 Acetylcholine A neurotransmitter found at neuromuscular junctions, autonomic ganglia, parasympathetic effector junctions, a subset of sympathetic effector junctions, and at many sites in the central nervous system. 2-(Acetyloxy)-N,N,N-trimethylethanaminium,Acetilcolina Cusi,Acetylcholine Bromide,Acetylcholine Chloride,Acetylcholine Fluoride,Acetylcholine Hydroxide,Acetylcholine Iodide,Acetylcholine L-Tartrate,Acetylcholine Perchlorate,Acetylcholine Picrate,Acetylcholine Picrate (1:1),Acetylcholine Sulfate (1:1),Bromoacetylcholine,Chloroacetylcholine,Miochol,Acetylcholine L Tartrate,Bromide, Acetylcholine,Cusi, Acetilcolina,Fluoride, Acetylcholine,Hydroxide, Acetylcholine,Iodide, Acetylcholine,L-Tartrate, Acetylcholine,Perchlorate, Acetylcholine
D000138 Acidosis A pathologic condition of acid accumulation or depletion of base in the body. The two main types are RESPIRATORY ACIDOSIS and metabolic acidosis, due to metabolic acid build up. Metabolic Acidosis,Acidoses,Acidoses, Metabolic,Acidosis, Metabolic,Metabolic Acidoses
D000142 Acidosis, Respiratory Respiratory retention of carbon dioxide. It may be chronic or acute. Respiratory Acidosis,Acidoses, Respiratory,Respiratory Acidoses
D014325 Tromethamine An organic amine proton acceptor. It is used in the synthesis of surface-active agents and pharmaceuticals; as an emulsifying agent for cosmetic creams and lotions, mineral oil and paraffin wax emulsions, as a biological buffer, and used as an alkalizer. (From Merck, 11th ed; Martindale, The Extra Pharmacopoeia, 30th ed, p1424) Tris Buffer,Trisamine,Trometamol,Tri(hydroxymethyl)aminomethane,Tris(hydroxymethyl)aminomethane,Tris-Magnesium(II)-Potassium Chloride Buffer,Tris-Mg(II)-KCl Buffer,Trizma

Related Publications

J Boon, and E Schretlen
September 1953, The Journal of the Oklahoma State Medical Association,
J Boon, and E Schretlen
March 1978, Pediatric annals,
J Boon, and E Schretlen
April 1973, British medical journal,
J Boon, and E Schretlen
July 1973, British medical journal,
J Boon, and E Schretlen
October 1972, Pediatrics,
J Boon, and E Schretlen
September 1986, Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde,
J Boon, and E Schretlen
June 1973, British medical journal,
J Boon, and E Schretlen
November 1970, Pediatric clinics of North America,
J Boon, and E Schretlen
July 1971, Nihon Ishikai zasshi. Journal of the Japan Medical Association,
J Boon, and E Schretlen
January 1984, Akusherstvo i ginekologiia,
Copied contents to your clipboard!